KEGG   DRUG: Beperminogene perplasmid
Entry
D09839                      Drug                                   
Name
Beperminogene perplasmid (JAN/INN)
Remark
ATC code: C05XX01
Efficacy
Antiparkinsonian, Angiogenesis inducing agent
  Type
Gene therapy product
Comment
Naked plasmid encoding human HGF gene [HSA:3082]Treatment of ischemic disease
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C05 VASOPROTECTIVES
   C05X OTHER VASOPROTECTIVES
    C05XX Other vasoprotectives
     C05XX01 Beperminogene perplasmid
      D09839  Beperminogene perplasmid (JAN/INN)
New drug approvals in Japan [br08318.html]
 Cellular and gene therapy products
  D09839
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09839
Other DBs
CAS: 627861-07-8
PubChem: 124490578
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system